ASPEN:  10,787   +189 (+1.78%)  19/04/2019 00:00

Aspen to split South African commercial pharmaceutical business

JOHANNESBURG, March 7 (Reuters) - Multinational drugmaker Aspen Pharmacare said it will split its South African Commercial Pharmaceuticals business into two distinct divisions as part of a strategic review of its South African and European operations.

Aspen, with a presence in 56 countries spanning six continents, said on Thusday the split would improve its focus on products and customers.

In its half-year results statement, it said a second phase of the review would concentrate on developing strategies specific to each division, although it did not say what the two divisions would be.

(Reporting by Nqobile Dludla; Editing by Kirsten Donovan)

2019-03-07 17:59:15

© 2019 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.